Shares of Medtronic (NYSE: MDT) are down 40% from their 2021 high. The dividend yield is a historically high 3.6%. Although this medical device maker is deeply unloved, now could be a good time for savvy investors to start adding it to their portfolios. Here's why. On the profitability side, the medical device maker has been readjusting its product portfolio to focus on its highest margin businesses. Included in that process is the spin-off of the company's diabetes division as MiniMed (NASDAQ: MMED). That ...